Skip to main content
Equibles

NATIXIS ADVISORS, LLC

Position in RVTY — Revvity, Inc.

CIK 1018331 Boston, MA
Back to RVTY Full portfolio

Position in RVTY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,234,865
+$14,898,930 QoQ
Shares Held
199,846
+138.7% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#49
of 543 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 45% Shared 0% None 55%

Common Shares in RVTY Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $1,134,714,630 across 20 Diagnostics & Research names. RVTY ranks #11 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 535,154 $268,304,808
2 DHR
Danaher Corp /De/
 872,810 $166,252,848
3 WAT
Waters Corp /De/
 332,814 $124,818,562
4 LH
Labcorp Holdings Inc.
 434,693 $121,714,040
5 MEDP
Medpace Holdings, Inc.
 195,579 $103,576,682
6 ILMN
Illumina, Inc.
 456,654 $80,293,472
7 QGEN
Qiagen N.V.
 1,670,207 $65,305,093
8 IDXX
Idexx Laboratories Inc /De
 79,090 $41,636,139

All Filings in RVTY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,234,865 199,846
2026-03-31 $7,335,935 83,734
2025-06-30 $1,057,439 10,933
2025-03-31 $1,563,935 14,782
2024-12-31 $1,600,375 14,339
2024-09-30 $1,596,747 12,499
2024-06-30 $1,111,306 10,598
2023-09-30 $2,094,111 18,917
2023-03-31 $1,530,890 11,488
2022-12-31 $1,628,374 11,613
2022-09-30 $1,339,633 11,133
2022-06-30 $1,751,154 12,313
2022-03-31 $3,756,996 21,535
2021-12-31 $3,703,123 18,418
2021-09-30 $2,352,411 13,575
2021-06-30 $1,816,170 11,762